- Report
- May 2025
- 181 Pages
Global
From €3184EUR$3,545USD£2,715GBP
€3538EUR$3,939USD£3,017GBP
- Report
- April 2025
- 141 Pages
Global
From €2693EUR$2,999USD£2,297GBP
- Report
- February 2025
- 200 Pages
Global
From €4032EUR$4,490USD£3,439GBP
- Report
- June 2025
- 233 Pages
Global
From €5254EUR$5,850USD£4,481GBP
- Report
- July 2024
- 100 Pages
Global
From €3368EUR$3,750USD£2,872GBP
- Report
- April 2025
- 149 Pages
Global
From €2838EUR$3,160USD£2,420GBP
€3547EUR$3,950USD£3,026GBP
- Report
- December 2024
Global
From €6736EUR$7,500USD£5,745GBP
- Report
- May 2025
- 198 Pages
Global
From €3184EUR$3,545USD£2,715GBP
€3538EUR$3,939USD£3,017GBP
- Report
- March 2025
- 325 Pages
Global
From €4445EUR$4,950USD£3,791GBP
- Report
- May 2025
- 193 Pages
Global
From €3184EUR$3,545USD£2,715GBP
€3538EUR$3,939USD£3,017GBP
- Report
- July 2024
- 140 Pages
Global
From €2693EUR$2,999USD£2,297GBP
- Report
- April 2025
- 145 Pages
Global
From €2693EUR$2,999USD£2,297GBP
- Report
- March 2025
- 145 Pages
Global
From €2693EUR$2,999USD£2,297GBP
- Report
- August 2024
- 175 Pages
Global
From €2057EUR$2,290USD£1,754GBP
- Report
- April 2025
- 200 Pages
Global
From €4032EUR$4,490USD£3,439GBP
- Report
- June 2025
- 192 Pages
Global
From €5254EUR$5,850USD£4,481GBP
- Report
- June 2025
- 179 Pages
Global
From €5254EUR$5,850USD£4,481GBP
- Report
- April 2025
- 250 Pages
Global
From €4032EUR$4,490USD£3,439GBP
- Report
- May 2025
- 188 Pages
Global
From €3435EUR$3,825USD£2,930GBP
€4041EUR$4,500USD£3,447GBP
- Report
- July 2024
- 100 Pages
Global
From €3368EUR$3,750USD£2,872GBP

The Inferior Vena Cava Filter (IVCF) is a medical device used in the treatment of deep vein thrombosis (DVT). It is a small, umbrella-like device that is inserted into the inferior vena cava, the largest vein in the body, to prevent blood clots from traveling to the lungs and causing a pulmonary embolism. IVCFs are used when anticoagulant medications are not effective or when a patient is at high risk for a pulmonary embolism.
The IVCF market is a segment of the larger cardiovascular devices market. It is a growing market, driven by the increasing prevalence of deep vein thrombosis and the need for effective treatments. The market is expected to benefit from technological advancements in the design and materials used in IVCFs, as well as the increasing number of clinical trials and studies conducted on the efficacy of IVCFs.
Some of the major companies in the IVCF market include Boston Scientific, Cook Medical, C.R. Bard, and B. Braun. Show Less Read more